By analyzing thousands of genetic risk variants, a new algorithm developed by Columbia researchers may be able to predict your risk of developing chronic kidney disease decades before onset.
Using advanced imaging methods, researchers have gained insight into how a common target of drugs sends cellular signals, a finding that may lead to better and more precise therapeutics.
Six scientists at Columbia have received NIH “High-Risk” grants that support exceptionally creative scientists and unconventional approaches to solving major challenges in medicine.
The grant to the Vagelos College of Physicians and Surgeons will help medical researchers speed the application of scientific discoveries, so that new treatments can be delivered to patients faster.
Wang received the prize, awarded annually to immigrants whose work demonstrates exceptional insight or innovation, for his development of synthetic biology tools.
With $10 million from Pfizer, the Initiative aims to increase the participation of underrepresented minorities in clinical trials and enhance the diversity of clinical researchers.
Researchers at Columbia University Vagelos College of Physicians and Surgeons are leading the first U.S. trial of an experimental vaccine designed to treat an opioid use disorder.
A new preclinical study provides the first direct evidence that loss of a placental hormone during pregnancy alters long-term brain development, causing autism-like behaviors in male offspring.
Keith Diaz, May Hua, Jennifer Woo Baidal, and Hanrui Zhang will receive funding over the next three years to support their clinical and translational research.
A fat ‘shield’ that protects natural killer cells from self-destruction also allows some cancer cells to evade destruction by the immune system, researchers at Columbia University have found.